CVS Health (NYSE:CVS) Rating Increased to Strong-Buy at Leerink Partnrs

Leerink Partnrs upgraded shares of CVS Health (NYSE:CVSFree Report) from a hold rating to a strong-buy rating in a report released on Wednesday,Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s FY2027 earnings at $8.23 EPS and FY2028 earnings at $9.36 EPS.

A number of other analysts also recently weighed in on the company. Royal Bank of Canada dropped their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. UBS Group lowered their price objective on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating for the company in a report on Tuesday. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday. Finally, Truist Financial raised their price objective on CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $70.28.

Read Our Latest Report on CVS Health

CVS Health Trading Up 4.9 %

Shares of CVS Health stock opened at $66.35 on Wednesday. The company has a 50 day simple moving average of $50.71 and a two-hundred day simple moving average of $55.94. The firm has a market cap of $83.49 billion, a PE ratio of 16.84, a PEG ratio of 0.60 and a beta of 0.61. CVS Health has a 1 year low of $43.56 and a 1 year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVSGet Free Report) last announced its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. Analysts expect that CVS Health will post 5.14 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.01%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Institutional Trading of CVS Health

Hedge funds have recently made changes to their positions in the stock. AMF Tjanstepension AB raised its position in shares of CVS Health by 124.1% in the 3rd quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock worth $3,882,000 after purchasing an additional 34,198 shares during the last quarter. Exchange Traded Concepts LLC lifted its stake in shares of CVS Health by 61.9% in the third quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock worth $934,000 after buying an additional 5,679 shares in the last quarter. Creative Planning grew its holdings in shares of CVS Health by 23.5% during the third quarter. Creative Planning now owns 250,891 shares of the pharmacy operator’s stock valued at $15,776,000 after buying an additional 47,737 shares during the last quarter. nVerses Capital LLC bought a new stake in shares of CVS Health during the third quarter valued at approximately $101,000. Finally, Secure Asset Management LLC raised its holdings in CVS Health by 38.4% in the 3rd quarter. Secure Asset Management LLC now owns 29,247 shares of the pharmacy operator’s stock worth $1,839,000 after acquiring an additional 8,121 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

About CVS Health

(Get Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Stories

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.